Search Results - Christian Freudlsperger
- Showing 1 - 6 results of 6
-
1
-
2
-
3
Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake—A randomized pilot trial by Oliver Ristow, Thomas Rückschloß, Julius Moratin, Michael Müller, Reinald Kühle, Dominik Horn, Maximilian Pilz, Veronika Shavlokhova, Sven Otto, Jürgen Hoffmann, Christian Freudlsperger
Published 2020Artigo -
4
Treatment delay and tumor size in patients with oral cancer during the first year of the <scp>COVID</scp>‐19 pandemic by Karl Metzger, Jan Mrosek, Sven Zittel, Maximilian Pilz, Thomas Held, Sebastian Adeberg, Oliver Ristow, Jürgen Hoffmann, Michael Engel, Christian Freudlsperger, Julius Moratin
Published 2021Artigo -
5
Phosphorylation of <scp>AKT</scp>(<scp>S</scp>er473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma by Christian Freudlsperger, Dominik Horn, Sebastian Wolfgang Weißfuß, Wilko Weichert, Klaus‐Josef Weber, Daniel Saure, Sarika Sharma, Gerhard Dyckhoff, Niels Grabe, Peter K. Plinkert, Jürgen Hoffmann, Kolja Freier, Jochen Heß
Published 2014Artigo -
6
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers by Mustafa Syed, Paul Flechsig, Jakob Liermann, Paul Windisch, Fabian Staudinger, Sati Akbaba, Stefan A. Koerber, Christian Freudlsperger, P. K. Plinkert, Jürgen Debus, Frederik L. Giesel, Uwe Haberkorn, Sebastian Adeberg
Published 2020Artigo
Search Tools:
Related Subjects
Biology
Internal medicine
Medicine
Cancer
Head and neck cancer
Cancer research
Cell biology
Head and neck squamous-cell carcinoma
Signal transduction
Dentistry
Gene
Genetics
PI3K/AKT/mTOR pathway
Pathology
Phosphorylation
Protein kinase B
Radiation therapy
Surgery
Apoptosis
Basal cell
Biochemistry
Biodistribution
Bioinformatics
Biotechnology
Carcinogenesis
Celastrol
Cell growth
Clinical endpoint
Clinical trial
Context (archaeology)